Who owns MONTE ROSA THERAPEUTICS INC?
- Ticker: GLUE
- CUSIP Number: 61225m102
Tip: Access positions for across all investors
Analyze quarterly positions in Monte Rosa Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Monte Rosa Therapeutics stock
Who bought or sold MONTE ROSA THERAPEUTICS INC this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
|---|---|---|---|---|---|
| NEA Management Company | 7.7M | $53M | 0% | Dec 2024 |
|
| T. Rowe Price Associates | 7.1M | $49M | 8% | Dec 2024 |
|
| Versant Venture Management | 5.7M | $39M | 100% | Dec 2024 |
|
| FMR | 5.5M | $39M | 9% | Dec 2024 |
|
| Baker Bros. Advisors | 4.9M | $34M | 0% | Dec 2024 |
|
| venBio Select Advisor | 4.3M | $30M | -25% | Dec 2024 |
|
| BlackRock | 3.8M | $27M | 32% | Dec 2024 |
|
| Vanguard Group | 3.2M | $22M | 25% | Dec 2024 |
|
| BVF | 2.8M | $19M | 100% | Dec 2024 |
|
| Morgan Stanley | 2.3M | $16M | 1700% | Dec 2024 |
|
| Suvretta Capital Management | 1.6M | $11M | -41% | Dec 2024 |
|
| Aisling Capital Management | 1.5M | $10M | 0% | Dec 2024 |
|
| Alphabet | 1.5M | $10M | 0% | Dec 2024 |
|
| State Street Corporation | 1.1M | $7.5M | 57% | Dec 2024 |
|
| Geode Capital Management | 1.0M | $7.2M | -1% | Dec 2024 |
|
| Citadel Advisors | 855k | $5.9M | -32% | Dec 2024 |
|
| Marshall Wace | 500k | $3.5M | 187% | Dec 2024 |
|
| Norges Bank Investment Management | 446k | $3.1M | 100% | Dec 2024 |
|
| Vestal Point Capital | 425k | $2.9M | -54% | Dec 2024 |
|
| Northern Trust | 377k | $2.6M | 5% | Dec 2024 |
|
| Charles Schwab Investment Management | 371k | $2.6M | 7% | Dec 2024 |
|
| Parkwood | 323k | $2.2M | -24% | Dec 2024 |
|
| Ikarian Capital | 312k | $2.2M | 0% | Dec 2024 |
|
| Two Sigma Investments | 279k | $1.9M | 1965% | Dec 2024 |
|
| Renaissance Technologies | 246k | $1.7M | 12% | Dec 2024 |
|
| Wellington Management Company | 222k | $1.5M | 2% | Dec 2024 |
|
| TD Asset Management | 220k | $1.5M | 14% | Dec 2024 |
|
| Susquehanna International | 214k | $1.5M | 201% | Dec 2024 |
|
| Bank of New York Mellon | 170k | $1.2M | 2% | Dec 2024 |
|
| Goldman Sachs Group | 160k | $1.1M | -10% | Dec 2024 |
|
| Jump Financial | 155k | $1.1M | 100% | Dec 2024 |
|
| Dimensional Fund Advisors | 145k | $1.0M | 4% | Dec 2024 |
|
| Manufacturers Life Insurance Company | 117k | $815k | 0% | Dec 2024 |
|
| Nuveen Asset Management | 103k | $714k | 0% | Dec 2024 |
|
| Quest Partners | 95k | $657k | 100% | Dec 2024 |
|
| Cubist Systematic Strategies | 93k | $644k | 100% | Dec 2024 |
|
| Boothbay Fund Management | 91k | $633k | 0% | Dec 2024 |
|
| Qube Research & Technologies | 87k | $601k | 100% | Dec 2024 |
|
| Casdin Capital | 86k | $597k | 0% | Dec 2024 |
|
| American Century Companies | 77k | $533k | 27% | Dec 2024 |
|
| Barclays | 71k | $491k | 30% | Dec 2024 |
|
| Wells Fargo & Company | 70k | $487k | 216% | Dec 2024 |
|
| D. E. Shaw & Co | 70k | $487k | 283% | Dec 2024 |
|
| Bank of America Corporation | 63k | $439k | -14% | Dec 2024 |
|
| Rhumbline Advisers | 62k | $289k | 1% | Mar 2025 |
|
| UBS Group | 59k | $412k | 134% | Dec 2024 |
|
| Millennium Management | 46k | $322k | 51% | Dec 2024 |
|
| Citigroup | 45k | $312k | 49% | Dec 2024 |
|
| Long Corridor Asset Management | 40k | $278k | 0% | Dec 2024 |
|
| Walleye Trading Advisors | 40k | $275k | 100% | Dec 2024 |
|
| Alliancebernstein | 35k | $244k | 0% | Dec 2024 |
|
| State of Wisconsin Investment Board | 32k | $225k | -11% | Dec 2024 |
|
| Corton Capital | 32k | $225k | 100% | Dec 2024 |
|
| Squarepoint Ops | 32k | $220k | 100% | Dec 2024 |
|
| Exchange Traded Concepts | 30k | $207k | 0% | Dec 2024 |
|
| Deutsche Bank Aktiengesellschaft | 29k | $202k | 30% | Dec 2024 |
|
| Rafferty Asset Management | 28k | $192k | 100% | Dec 2024 |
|
| Franklin Resources | 28k | $191k | 100% | Dec 2024 |
|
| Two Sigma Advisers | 26k | $180k | 100% | Dec 2024 |
|
| MetLife Investment Advisors | 25k | $173k | 0% | Dec 2024 |
|
| Mirae Asset Global Etfs Holdings | 25k | $173k | 9% | Dec 2024 |
|
| Jpmorgan Chase & Co | 24k | $167k | 30% | Dec 2024 |
|
| Intech Investment Management | 23k | $161k | 61% | Dec 2024 |
|
| EcoR1 Capital | 22k | $151k | 100% | Dec 2024 |
|
| Corebridge Financial | 21k | $143k | 100% | Dec 2024 |
|
| Sei Investments | 17k | $120k | 100% | Dec 2024 |
|
| Florida State Board of Administration | 15k | $104k | 0% | Dec 2024 |
|
| Jane Street | 15k | $101k | -13% | Dec 2024 |
|
| ProShare Advisors | 15k | $101k | 100% | Dec 2024 |
|
| Sherbrooke Park Advisers | 15k | $101k | -28% | Dec 2024 |
|
| China Universal Asset Management | 13k | $90k | 100% | Dec 2024 |
|
| Invesco | 13k | $89k | 100% | Dec 2024 |
|
| New York State Common Retirement Fund | 12k | $84k | 0% | Dec 2024 |
|
| Ing Investment Management | 12k | $84k | -7% | Dec 2024 |
|
| Colony | 11k | $77k | 100% | Dec 2024 |
|
| Virtus ETF Advisers | 9.1k | $63k | 100% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 6.2k | $43k | 100% | Dec 2024 |
|
| Royal Bank of Canada | 5.6k | $42k | 25% | Dec 2024 |
|
| Tower Research Capital | 5.4k | $38k | 193% | Dec 2024 |
|
| Summit Investment Advisors | 4.2k | $29k | 0% | Dec 2024 |
|
| Legal & General Group | 3.6k | $25k | -78% | Dec 2024 |
|
| California State Teachers Retirement System | 3.0k | $21k | 0% | Dec 2024 |
|
| Advisor Group Holdings | 3.0k | $21k | 179% | Dec 2024 |
|
| NISA Investment Advisors | 2.8k | $20k | 3% | Dec 2024 |
|
| Mirae Asset Global Investments | 2.0k | $15k | 100% | Dec 2024 |
|
| Sterling Capital Management | 1.3k | $9.2k | 801% | Dec 2024 |
|
| Gf Fund Management | 1.3k | $9.0k | 100% | Dec 2024 |
|
| GAMMA Investing | 1.2k | $5.7k | -79% | Mar 2025 |
|
| Brian McDonald | 1.1k | $7.7k | 32% | Dec 2024 |
|
| Amalgamated Bank | 995.00 | $7.0k | 0% | Dec 2024 |
|
| Toronto-Dominion Bank | 800.00 | $5.6k | 100% | Dec 2024 |
|
| SBI Securities | 652.00 | $4.5k | 100% | Dec 2024 |
|
| Northwestern Mutual Wealth Management Company | 300.00 | $2.1k | 0% | Dec 2024 |
|
| Point72 Asset Management | 250.00 | $1.7k | 100% | Dec 2024 |
|
| Daiwa Securities Group | 203.00 | $999.998300 | 100% | Dec 2024 |
|
| CWM | 116.00 | $1.0k | 107% | Dec 2024 |
|
| Rothschild Investment | 50.00 | $232.000000 | -58% | Mar 2025 |
|
| Pnc Financial Services | 28.00 | $194.000800 | 0% | Dec 2024 |
|
| Us Bancorp | 26.00 | $180.000600 | 100% | Dec 2024 |
|
| EverSource Wealth Advisors | 4.00 | $28.000000 | 100% | Dec 2024 |
|
Who sold out of Monte Rosa Therapeutics?
Fund or Company Name |
Date Sold |
Shares Held |
Valued At |
|---|---|---|---|
| ExodusPoint Capital Management | Sep 2024 | 394k | $2.1M |
| Sphera Funds Management | Sep 2024 | 118k | $626k |
| Acadian Asset Management | Sep 2024 | 111k | $586k |
| Hrt Financial | Sep 2024 | 39k | $206k |
| EntryPoint Capital | Sep 2024 | 33k | $176k |
| Bridgeway Capital Management | Sep 2024 | 25k | $133k |
| Ubs Global Asset Management Americas | Sep 2024 | 24k | $128k |
| CornerCap Investment Counsel | Sep 2024 | 19k | $102k |
| SG Americas Securities | Dec 2024 | 17k | $116k |
| Janney Montgomery Scott | Dec 2024 | 13k | $92k |
| Meeder Asset Management | Sep 2024 | 10k | $53k |
| Capital Performance Advisors | Sep 2024 | 29.00 | $153.998700 |